9960 — Kindstar Globalgene Technology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapTurnaround

Annual balance sheet for Kindstar Globalgene Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	71.1	896	2,145	2,001	2,025
Net Total Accounts Receivable
Net Total Receivables	305	314	342	639	581
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	446	1,355	2,570	2,749	2,709
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	169	158	373	399	478
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	664	1,577	3,189	3,725	3,669
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,435	531	452	862	744
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1,469	3,421	469	899	797
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-804	-1,844	2,720	2,827	2,872
Total Liabilities & Shareholders' Equity	664	1,577	3,189	3,725	3,669
Total Common Shares Outstanding